In tumor cells, it has been reported that Nrf2 activity is inhibited by blocking Nrf2 protein transfer from the cytoplasm into the nucleus, which makes cancer resistant to chemotherapeutic drugs and inhibits the occurrence of apoptosis (22). This evidence concerns the gene NFE2L2 and cancer.